Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC Benzyl ((2S)-1-(((3-bromo-4,5-dihydroisoxazol-5-yl)methyl)amino)-3-(4-hydroxyphenyl)-1-oxopropan-2-yl) | 744198-19-4 | MFCD12032123 | 98.1% | 476.32 g/mol | C21H22BrN3O5 | 100MG
SDP

Supplier:  Medchemexpress LLC HY123290100MG

Encompass_Preferred

KCC009 is a small-molecule transglutaminase 2 (TG2) inhibitor for research use; it induces p53-independent radiosensitization and is supplied as both solid and DMSO solution forms to support in vitro and in vivo studies.

  • Potent transglutaminase 2 (TG2) inhibitor that modulates radiosensitivity.
  • Induces p53-independent radiosensitization in cell models.
  • Available as solid and as DMSO solution for flexible dosing and formulation.
  • High purity (~98.1%) suitable for research applications.
  • Highly soluble in DMSO (≈250 mg/mL) enabling convenient stock preparation.
  • Characterized by CAS 744198-19-4 and molecular formula C21H22BrN3O5.

Catalog No. 50-002-37415


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.